A scheduled system update will be performed from 3 PM PST on Friday, October 17th to 9 PM PST on Saturday, October 18th. During this timeframe, online ordering on beckman.com will be temporarily unavailable. For urgent orders, please contact: LSOrders@beckman.com (North America), LSEuropeOrders@beckman.com (Europe). We appreciate your understanding and patience as we continue to enhance your online experience.
Beckman Coulter Life Sciences and Illumina Accelerate Oncology Research with Launch of TruSight Oncology 500 DNA/RNA Application<strong>Indianapolis, IN – (August 6, 2024)</strong> Beckman Coulter Life Sciences offers a promising new approach to oncology research delivering faster results with fewer touchpoints. The Illumina TruSight™ Oncology 500 DNA/RNA assay on the Biomek NGeniuS System from Beckman Coulter Life Sciences provides an innovative automated solution enabling comprehensive genomic profiling of tumor samples.
IMPORTANT: Beckman Coulter makes no warranties of any kind whatsoever express or implied, with respect to this App Template, including but not limited to warranties of fitness for a particular purpose or merchantability or that the App Template is non-infringing. All warranties are expressly disclaimed. Your use of the App Template is solely at your own risk, without recourse to Beckman Coulter. This App Template has been demonstrated for use on the Biomek NGeniuS system for the chemistry kit version and the release date shown at the time when the App is selected and created, but has not been validated by Beckman Coulter for use in the diagnosis of disease or other clinical conditions.
Products and demonstrated applications are not intended or validated for use in diagnostic procedures.